GlassScriptPhysician profile
Ericka Mckay Sohlberg
NPI 1881034601
$2,910.60
in general payments reported to CMS, 2019-2025
23 companies · $715 in 2025
The $715 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.73 · 2021: $75.91 · 2022: $720 · 2023: $492 · 2024: $864 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,965 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,965.43 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $105.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $328.33 | 2025 | |
| Abbvie INC. | $302.81 | 2022-2025 | Botox |
| Sumitomo Pharma America, INC. | $252.82 | 2024 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $248.60 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700 |
| Procept Biorobotics Corporation | $203.55 | 2022-2025 | Aquabeam Robotic System |
| Axonics, INC. | $201.40 | 2022 | |
| Palette Life Sciences, INC. | $174.69 | 2022 | |
| Medtronic, INC. | $173.48 | 2024 | Signia |
| Teleflex LLC | $138.25 | 2022 | |
| Biotissue Holdings INC. | $130.98 | 2023 | |
| Immunitybio, INC. | $122.60 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $122.25 | 2024 | Adstiladrin |
| Photocure INC | $105.51 | 2023 | Cysview |
| Coloplast Corp | $99.03 | 2021-2025 | |
| Ambu INC. | $61.61 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $55.94 | 2022 | |
| Urogen Pharma, INC. | $48.93 | 2023-2025 | Jelmyto |
| Lumenis, INC | $37.02 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $26.36 | 2025 | Exparel |
| Amgen INC. | $20.88 | 2022 | |
| Angiodynamics, INC. | $20.05 | 2025 | Nanoknife |
| Tolmar Pharmaceuticals, INC. | $18.96 | 2021 | |
| Tolmar, INC. | $16.55 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ericka Sohlberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.